Gradalis, Inc.

Printer-friendly versionSend to friend

Gradalis is a vertically integrated biotechnology company committed to developing core technologies poised to deliver therapeutics that offer safer and more effective treatments for cancer.

Our Story

The Company has two primary platforms, one centered on personalized autologous vaccines and a second focused on bifunctional short hairpins RNA (shRNA) to enable specific protein knockdown.  In addition, Gradlis has numerous partnerhsips and joint ventures that provide it with access to other cutting edge clinical and pre-clinical stage programs.

Gradalis, Inc. is a fully integrated biotechnoogy company based in Dallas, Texas that focuses on teh development, manufacturing and commercialization of drugs, vaccines, tools and diagnostics primarily in the area of cancer.  Gradalis has its onw GMP manufacturing facilility along with highly skilled technical leadership and staff and a strategic partnership with Mary Crowley Cancer Research Centers for clinical development of Gradalis products.